Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

Blood

Volumn 97, Issue 10, 2001, Pages 3161-3170

  Lopatin, Uri ^a,b   Yao, Xu ^a,b   Williams, Richard K ^a,b   Blessing, Jack J H ^a,b   Dale, Janet K ^a,b   Wong, David ^a,b   Teruya Feldstein, Julie ^a,b   Fritz, Scott ^a,b   Morrow, Matthew R ^a,b   Fuss, Ivan ^a,b   Sneller, Michael C ^a,b   Raffeld, Mark ^a,b   Fleisher, Thomas A ^a,b   Puck, Jennifer M ^a,b   Strober, Warren ^a,b   Jaffe, Elaine S ^a,b   Straus, Stephen E ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 10; MESSENGER RNA;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SPLENOMEGALY; T LYMPHOCYTE;

EID: 0035874537     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3161     Document Type: Article

References (42)

1. Sneller MC, Straus SE, Jaffe ES, Fleisher TA, Stetler-Stevenson M, Strober W. A novel lymphoproliferative/autoimmune syndrome resembling murine Ipr/gld disease. J Clin Invest. 1992;90:334-341.
2. Fisher GH, Rosenberg GH, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
3. Rieux-Laucat F, LeDeist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
4. Straus SE (moderator), Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome [NIH conference]. Ann Intern Med. 1999;130:591-601.
5. Drappa J, Vaishnau AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med. 1996;335:1643-1649.
6. Kellerer K, Mutz I. Chronic pseudomalignant immune proliferation (Canale-Smith syndrome [author's transl]. Eur J Pediatr. 1976;121:203-213.
7. Malzberg MS, Haller JO, Snieckus PJ, Halpern SL. Canale-Smith syndrome: chronic pseudomalignant lymphadenopathy. J Clin Ultrasound. 1991;19:172-174.
8. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243-269.
9. Sneller MC, Wang K, Dale JK, Strober W, Middleton LA, Straus SE. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89:1341-1348.
10. Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541-1550.
11. Puck JM, Sneller MC: ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Semin Immunol. 1997;9:77-84.
12. Bettinardi A, Brugnoni D, Quirús-Roldan E, et al. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood. 1997;89:902-909.
13. LeDeist F, Emile J-F, Rieux-Laucat F, et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet. 1996;348:719-723.
14. Infante AJ, Britton HA, DiNapoli T, et al. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs'lymphocyte apoptosis. J Pediatr. 1998;133:629-633.
15. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 1996;98:1107-1113.
16. Wang J, Zheng L, Lobito A, et al. Inherited human caspase-10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome, type II. Cell. 1999;98:47-58.
17. Dianzani U, Bragardo M, DiFranco D, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood. 1997;89:2871-2879.
18. Puck JM, Straus SE, LeDeist F, Rieux-Laucat R, Fischer A. Inherited disorders with autoimmunity and defective lymphocyte regulation. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York, NY: Oxford University Press; 1999:339-352.
19. Fuss IJ, Strober W, Dale JK, et al. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol. 1997;158:1912-1918.
20. Togawa A, Inoue N, Miyamoto K, Hyodo H, Namba M. Establishment and characterization of a human myeloma cell line (KMM-1). Int J Cancer. 1982;29:495-500.
21. Teruya-Feldstein J, Jaffe ES, Burd PR, Kingma DW, Setsuda JE, Tosato G.: Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood. 1999;93:2463-2470.
22. Elenitoba-Johnson KS, Kumar S, Lim MS, Kingma DW, Raffeld M, Jaffe ES. Marginal zone B-cell lymphoma with monocytoid B-cell lymphocytes in pediatric patients without immunodeficiency. A report of two cases. Am J Clin Pathol. 1997;107:92-98.
23. deWaal Malefyt R, Abrams J, Bennett B, Figdor CG, deVries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209-1220.
24. Cohen SB, Crawley JB, Kahan MC, Feldmann M, Foxwell BM. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology. 1997;92:1-5.
25. Itoh K, Hirohata S. The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol. 1995;154:4341-4350.
26. + hematopoietic progenitor cells. Blood. 1996;88:2549-2558.
27. Kitabayashi A, Hirokawa M, Miura AB. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int J Hematol. 1995;62:99-106.
28. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest. 1994;93:424-428.
29. Cory S. Cell death throes. Proc Natl Acad Sci U S A. 1998;95:12077-12079.
30. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
31. Haas JP, Grunke M, Frank C, et al. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation. Cell Death Differ. 1998;5:751-757.
32. Cush JJ, Splawski JB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:96-104.
33. Llorente L, Richaud-Patin Y, Fior R, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sj6gren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994;37:1647-1655.
34. Hagiwara E, Gourley MF, Lee S, Klinman DK. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of intedeukin-10:inteferon-γ secreting cells in the peripheral blood. Arthritis Rheum. 1996;39:379-385.
35. Llorente L, Zou W, Levy Y, et al. Role of interleukin-10 in the B lymphocyte hyperactivity and antoantibody production of human systemic lupus erythmatosus. J Exp Med. 1995;181:839-844.
36. 1 mice. J Exp Med. 1994;179:305-310.
37. Ishida H, Hastings R, Kearney J, Howard M. Continuous anti-interleukin-10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med. 1992;175:1213-1220.
38. Prud'homme GJ, Kono DH, Theofilopoulos AN. Quantitative polymerase chain-reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10, and interferon-γ messenger RNA in the lymph nodes of lupus-prone mice. Mol Immunol. 1994;32:495-503.
39. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet. 1999;64:1002-1014.
40. Vaishnaw AK, Orlinick JR, Chu JL, Krammer PJ, Chao MV, Elkon KB. The molecular basis for apoplotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest. 1999;103:355-363.
41. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythmatosus. Tissue Antigens. 1997;49: 635-639.
42. Lazarus M, Hajeer AH, Turner D, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythmatosus. J Rheumatol. 1997;24:2314-2317.